Protagonist Therapeutics, Inc. (PTGX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
| Previous close | 26.09 |
| Open | 26.10 |
| Bid | 25.97 x 300 |
| Ask | 32.90 x 200 |
| Day's range | 25.54 - 26.31 |
| 52-week range | 13.72 - 33.34 |
| Volume | |
| Avg. volume | 570,380 |
| Market cap | 1.528B |
| Beta (5Y monthly) | 2.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We Might See A Profit From Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Soon
With the business potentially at an important milestone, we thought we'd take a closer look at Protagonist...
- Zacks
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- GuruFocus.com
Protagonist Therapeutics Inc CEO Sells 25,000 Shares
Protagonist Therapeutics Inc (NASDAQ:PTGX), a biopharmaceutical company, has reported an insider sale according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.